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Following acute infection, bovine herpesvirus 1 establishes latency in sensory neurons of trigeminal ganglia
(TG). Reactivation from latency occurs periodically, resulting in the shedding of infectious virus. The latencyrelated (LR) RNA is abundantly expressed in TG of latently infected calves, and the expression of LR proteins
is necessary for dexamethasone-induced reactivation from latency. Previously published studies also identified
an alternatively spliced LR transcript which is abundantly expressed in TG at 7 days after infection and has
the potential to encode a novel LR fusion protein. Seven days after infection is when extensive viral gene
expression is extinguished in TG and latency is established, suggesting that LR gene products influence the
establishment of latency. In this study, we used a bacterial two-hybrid assay to identify cellular proteins that
interact with the novel LR fusion protein. The LR fusion protein interacts with two proteins that can induce
apoptosis (Bid and Cdc42) and with CCAAT enhancer binding protein alpha (C/EBP-␣). Additional studies
confirmed that the LR fusion protein interacts with human or insect C/EBP-␣. C/EBP-␣ protein expression is
induced in TG neurons of infected calves and after dexamethasone-induced reactivation from latency. Wildtype C/EBP-␣, but not a DNA binding mutant of C/EBP-␣, enhances plaque formation in bovine cells. We
hypothesize that interactions between the LR fusion protein and C/EBP-␣ promote the establishment of
latency.

Bovine herpesvirus-1 (BHV-1) is an Alphaherpesvirinae subfamily member (35) that establishes lifelong latency in ganglionic neurons of the peripheral nervous system following acute
replication in the mucosal epithelium. Infection of permissive
cells (13) or calves (65) leads to rapid cell death, in part due to
apoptosis. Infection can also cause conjunctivitis, pneumonia,
genital disorders, abortions, and a complex upper respiratory
tract infection referred to as shipping fever (bovine respiratory
complex) (59). BHV-1 transiently depresses cell-mediated immunity (8, 21–23), resulting in secondary bacterial infections
and pneumonia (shipping fever). BHV-1 infection and shipping fever cost the United States cattle industry at least $500
million/year (5, 46). Although modified live vaccines are available, they can cause disease in young calves or abortion in
pregnant cows.
Viral gene expression is regulated in three distinct phases:
immediate early (IE), early (E), or late (L). IE gene expression
is stimulated by a virion component, alpha gene trans-inducting
factor (44), and bICP0. The bICP0 protein is constitutively
expressed throughout productive infection because the gene
has an IE and E promoter. The bICP0 protein trans-activates
all viral promoters and thus promotes efficient productive infection (reviewed in references 36 and 38). IE proteins activate
E gene expression, and viral DNA replication ensues. L gene
expression then occurs, culminating in virion production.

The BHV-1 latency-related (LR) RNA is abundantly transcribed in latently infected neurons (40, 54, 55) and is antisense
to the bICP0 gene. The LR gene has two open reading frames
(ORF-1 and ORF-2) and two reading frames that lack an
initiating ATG (RF-B and RF-C) (Fig. 1, panel II). A fraction
of LR RNA is polyadenylated and alternatively spliced in trigeminal ganglia (TG), suggesting that different LR proteins
are expressed at specific times during the latency-reactivation
cycle (13, 27) (Fig. 1, panel I). One such transcript is expressed
in TG at 7 days after infection (7d cDNA) and has the potential to encode an ORF-2/ORF-1 fusion protein (Fig. 1, panel
III, LR fusion protein) (11, 12). When the 7d cDNA is expressed in insect cells from a recombinant baculovirus, a 40kDa protein is expressed (33).
A mutant BHV-1 strain with three stop codons at the N
terminus of ORF-2 (LR mutant virus) was constructed (30).
ORF-2 and RF-C are expressed in bovine cells infected with
wild-type (wt) or the LR-rescued virus but not in cells infected
with the LR mutant virus (33). Calves infected with the LR
mutant exhibit diminished clinical symptoms and reduced
shedding of infectious virus from the eye, TG, or tonsil (30, 31,
51). The LR mutant virus does not reactivate from latency
following treatment with dexamethasone (DEX) (31), whereas
all calves latently infected with wt virus or the LR-rescued virus
shed infectious virus following DEX treatment (31). Thus,
disruption of LR protein expression is necessary for DEXinduced reactivation from latency in calves. LR gene products
inhibit cell proliferation, bICP0 RNA expression (6, 18, 56),
and apoptosis (10). LR protein expression is necessary for
inhibiting apoptosis but not for cell growth or bICP0 expression (6, 16, 18, 56). It is not clear whether LR protein expres-
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FIG. 1. Schematic of LR gene and major ORF encoded by the 7d cDNA. (I) Map of the PstI-SalI fragment that contains the LR promoter,
5⬘ terminus of the LR transcript, ORF-E, and part of the bICP0 protein coding sequences. The 5⬘ end of the LR transcript in TG is located
upstream of the start site mapped during productive infection of cultured bovine cells (11, 12, 27). The positions of the 5⬘ and 3⬘ splice sites of
the 7d cDNA are shown above the latent LR transcript (12). These splice sites have not been detected during productive infection, and thus the
splice sites shown here are in the general region where splicing occurs. ORF-E is antisense relative to the LR gene (29). (II) The organization of
the major ORFs in the LR gene was described previously (40). Numbers on top indicate the genomic nucleotide positions, and those on the bottom
refer to amino acid positions. The hatched box denotes LR-ORF-1. RF-B (white box) and RF-C (black box) that follow LR-ORF-2 (stippled box)
do not contain a methionine at their respective amino termini. Stars denote the positions of in-frame stop codons. (III) Organization of the major
ORFs encoded by the 7d cDNA. NLS refers to the nuclear localization sequence and PA to proline/alanine-rich sequences present in the LR fusion
protein. Nucleotide numbers refer to the genomic sequence that was initially reported for the LR gene (40), and the numbers below the LR fusion
protein are amino acid numbers of the ORF.

sion enhances the establishment or maintenance of latency
and/or reactivation from latency.
In this study, we performed a two-hybrid screening to
identify cellular proteins that interact with the LR fusion
protein. Several such cellular proteins were identified. Two
of these proteins, Bid and Cdc42, can induce apoptosis.
Since the LR gene inhibits apoptosis (10, 43), the ability of
an LR protein to interact with proapoptotic cellular proteins
was expected. The LR fusion protein also interacts with
CCAAT enhancer binding protein alpha (C/EBP-␣) in the
two-hybrid assay. Independent studies confirmed that the
LR fusion protein interacts with insect or human C/EBP-␣.
Induction of C/EBP-␣ protein expression is detected in TG
neurons of acutely infected calves and DEX-induced reactivation from latency. The overexpression of wt C/EBP-␣,
but not a DNA binding mutant, also enhances productive
infection. Collectively, these studies suggest that interactions between the LR fusion protein and C/EBP-␣ repress
productive infection in TG neurons, thus enhancing the
establishment of latency.

MATERIALS AND METHODS
Cells and virus. Bovine kidney (MDBK) cells were grown in Earle’s modified
Eagle’s medium supplemented with 5% fetal calf serum (FCS). Human neuroblastoma cells (SK-N-SH) and bovine testicle cells (9.1.3) were grown in Earle’s
modified Eagle’s medium supplemented with 10% FCS. Spodoptera frugiperda
(SF9) insect cells were maintained in Grace’s supplemented insect medium
(Gibco) with 10% FCS. All media contained penicillin (10 U/ml) and streptomycin (100 g/ml).
The wt Cooper strain of BHV-1 was obtained from the National Veterinary
Services Laboratory, Animal and Plant Health Inspection Services (Ames, IA).
The BHV-1 gC-blue virus contains the ␤-galactosidase gene inserted into the
glycoprotein C gene, which was provided by S. Chowdhury (Kansas State University). A recombinant baculovirus expressing the 7d cDNA sequence (His66)
was described previously (33), and His66 was used to infect SF9 insect cells.
Plasmids. pBT7day was generated by cloning the SphI fragment of the 7d
cDNA (33) into the bait plasmid pBT. Cloning was done in such a way that the
LR fusion protein is in frame with the Escherichia coli cI repressor coding
sequences. The target plasmid (pTRG) contains a rat brain cDNA library fused
in frame to the RNA polymerase alpha subunit.
Plasmid pC/EBP-␣ contains the wt mouse C/EBP-␣ cDNA in an adenoviral
vector (pAdTrack) with corresponding mammalian expression promoter/enhancer
sequences (61). Plasmid pC/EBP-␣ 290mts contains a mutation that produces a
single amino acid change (R290A) in C/EBP-␣, which results in loss of DNA binding
activity (61). This mutant is referred to as C/EBP-␣⌬DB in this study.
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The bICP0 plasmid encodes bICP0 coding sequences cloned into a human
cytomegalovirus expression vector.
Bacterial two-hybrid assay. All procedures were performed according to recommendations of the manufacturers of the BacterioMatch II two-hybrid system
(Stratagene). An E. coli reporter strain was cotransformed with pBT7day and
pTRG containing the rat brain cDNA library. Cotransformants were screened by
using medium lacking histidine and containing 3-aminotriazole, as recommended
by the manufacturer. Positive interactions were further confirmed by activation
of the streptomycin resistance gene on selective plates. The pTRG plasmid
derived from positive interactions was isolated by standard methods. DNA sequencing reactions of the respective inserts in pTRG were performed at the
University of Nebraska DNA sequencing core facility. A BLAST search at the
NCBI website was performed to identify proteins encoded by the respective
cDNAs.
Binding assays. The His66 recombinant baculovirus, containing the 7d cDNA
expressed as a histidine-tagged protein (33), was used to infect SF9 cells. Cells
were collected when the cytopathic effect was 70 to 80%, lysed, and then loaded
on a 2-ml Ni⫹ column under (i) native or (ii) denaturing conditions, according to
the manufacturer’s recommendations (Probound, K850-01; Invitrogen).
(i) SF9 cells (infected or uninfected) were suspended in native binding buffer
(50 mM NaPO4, 500 mM NaCl, 10 mM imidazole [pH 8.0]), followed by three
freeze-thaw cycles and a final 10-min spin at 3,000 ⫻ g. Eleven milligrams of
protein was loaded onto the Ni⫹ column equilibrated with native binding
buffer and allowed to bind for 1 h at 4°C. Three washes of 10 ml each were
performed using native wash buffer (50 mM NaPO4, 500 mM NaCl, 20 mM
imidazole [pH 8]).
(ii) Lysis of SF9 cells (infected or uninfected) was conducted under denaturing
conditions by suspending cells in a solution of 6 M guanidine-HCl, 20 mM
NaPO4 (pH 7.8), and 500 mM NaCl. The cell lysate was passed through an
18-gauge needle to ensure total lysis. Eleven milligrams of total protein was
loaded onto the Ni⫹ column equilibrated with denaturing binding buffer (8 M
urea, 20 mM NaPO4, 500 mM NaCl [pH 7.8]) and allowed to bind for 1 h at 4°C.
The column was washed with denaturing binding buffer (pH 7.8 or 6 or 5.6) (two
washes for each pH; 4 ml in each wash).
After SF9 proteins were bound under denaturing conditions, the Ni⫹ column
was equilibrated in native binding buffer (see above) and blocked for 30 min with
0.01% bovine serum albumin (BSA) in native binding buffer at 4°C. SK-N-SH
cells were lysed in NP-40 lysis buffer, and 3 mg of protein was applied to the
column, which was incubated for 1 h at 4°C. Finally, native wash buffer was
applied to the column (three 10-ml washes).
In all cases, the contents of the column were analyzed by boiling the beads in
sodium dodecyl sulfate (SDS) reducing sample buffer, and the released proteins
were loaded on a 12% SDS-polyacrylamide gel electrophoresis (PAGE) gel.
After electrophoresis, proteins were transferred onto a polyvinylidene difluoride
(PVDF) membrane (Millipore), and Western blotting was performed using an
anti-C/EBP-␣ specific antibody (14AA; Santa Cruz Biotechnology).
SDS-PAGE and Western blotting. Standard 12% SDS-PAGE gels were prepared and used for these studies. Proteins were transferred to PVDF membrane
(Millipore), blocked for 1 h by using 5% nonfat dry milk with phosphate-buffered
saline–0.05% Tween 20 (PBS-T), and incubated with primary antibody overnight
at 4°C. The C/EBP-␣ antibody was diluted 1:500 in the blocking solution. After
30 min of washing with PBS-T, the blots were incubated with donkey anti-rabbit
horseradish peroxidase-conjugated immunoglobulin G (Amersham Biosciences),
which was diluted 1:1,000 in nonfat dry milk with PBS-T. Blots were washed for
30 min with PBS-T and exposed to Amersham ECL reagents, and then autoradiography was performed.
Immunohistochemistry. wt-infected calves were euthanized, and their TG
were fixed in neutral buffered formalin and then embedded in paraffin. Thin
sections (4 to 5 um) were cut and mounted onto slides. Tissue sections were
incubated for 20 min at 65°C, followed by two incubations of 10 min in xylene and
rehydration in graded alcohols. Tissue sections were then incubated with 3%
hydrogen peroxide in PBS (pH 7.4) for 20 min at room temperature to block
endogenous peroxidase. After three washes in Tris-buffered saline (TBS; 5 min
each) at room temperature, tissue sections were digested with 0.05% protease
XIV (P-5147; Sigma) in Tris buffer (0.05 M Tris, pH 7.6) for 20 min at 37°C.
Tissue sections were then blocked with 5% normal goat serum diluted in TBS
containing 0.25% BSA for 45 min at room temperature in a humidified chamber.
Primary anti-C/EBP-␣ antibody (sc-14AA; Santa Cruz Biotechnology) was
used at a 1:250 dilution, incubated overnight in a humidified chamber at 4°C, and
washed in TBS (pH 7.6) the next day. Biotinylated goat anti-rabbit immunoglobulin G (Vector Labs) was then incubated with the section for 30 min at room
temperature in a humidified chamber. Next, the avidin biotinylated enzyme
complex was added to slides for 30 min at room temperature in a humidified
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chamber. After three washes in TBS, slides were incubated with freshly prepared
substrate (Vector NovaRed substrate kit for peroxidase; Vector Labs), rinsed
with distilled water, and counterstained with hematoxylin. Thin sections from
mock-infected calves were used as a negative control.
RNA extraction. Extraction of RNA was performed as described by Chomczynski and Sacchi (9). Briefly, TG were minced into small pieces, placed into 10
ml of solution D (4 M guanidine thiocyanate, 25 mM sodium citrate [pH 7.0],
0.5% sarcosyl, 14 mM ␤-mercaptoethanol), and homogenized. After two phenol
extractions were performed, RNA concentrations were determined spectrophotometrically (260 nm) and RNA was reprecipitated in 3 volumes of ethanol.
RNA was prepared from MDBK cells using TRIzol reagent as described
previously (49, 50).
DNase I treatment and reverse transcription. Three micrograms of total RNA
was treated with 1 U of DNase I (Invitrogen) for 15 min at room temperature in
the presence of a RNase inhibitor (RNAsin; Promega, Madison, WI). After
DNase I treatment, samples were incubated at 65°C for 7.5 min in the presence
of 2 mM EDTA to eliminate DNase I activity. One microgram of total RNA
(DNase I treated) plus 1 g of random hexamers were incubated at 65°C for 7.5
min and then chilled on ice. Sixteen microliters of ice-cold reverse transcription
mix (20 mM Tris-HCl [pH 8.3], 50 mM KCl, 2.5 mM MgCl2), 100 g BSA/ml, 1
mM dithiothreitol, 0.5 mM (each) deoxynucleoside triphosphates, 10 U of RNasin,
and 100 U of reverse transcriptase (Invitrogen) was added. The reaction mixture
was incubated for 10 min at 25°C and then for 50 min at 42°C. As a control for
DNA contamination in RNA samples, 2 g of RNA (DNase I treated) was mixed
with ice-cold reverse transcription mix lacking RT.
PCRs. An aliquot (2 l) of the reverse transcription reaction mixture was used
for each PCR using primers specific for bovine C/EBP-␣ (⫹AGTCCGTGGAC
AAGAACAGC and ⫺GGTCATTGTCACTGGTCAGC). Bovine growth hormone (GH) primers (⫹GCTTTCGCCCTGCTCTGCC and ⫺TCCTGCCTCC
CCACCCCTA) were used as an internal control. PCRs were carried out in 50-l
reactions containing 5 mM MgCl2, 200 M concentrations of each deoxynucleoside triphosphate, 1 M concentrations of each primer, and 1 U Taq polymerase.
Five microliters of GC melt (Advantage GC-2; BD Biosciences) was then added
to the reaction mixture. Amplification was carried out with 37 cycles of denaturing at 95°C for 45 s, annealing at 53°C for 45 s, and extending at 72°C for 1
min. Upon completion of the last cycle, reactions were further incubated at 72°C
for 10 min to ensure complete extension of the amplified product. PCR products
were electrophoresed by using a 2% agarose gel.
Cell lysis and protein quantitation. MDBK or SK-N-SH whole-cell lysate was
prepared using NP-40 lysis buffer (1% NP-40, 50 mM Tris-HCl [pH 8], 150 mM
NaCl). The NP-40 lysis buffer also contained 1 tablet of protease inhibitor
cocktail (11 8361 53001; Roche) for each 10 ml of buffer. Protein concentrations
were measured using a Bradford reagent kit (500-0006; Bio-Rad).
Analysis of C/EBP-␣ expression on plaque formation. The gCblue virus
grows to titers similar to those for wt BHV-1 and was grown in MDBK cells.
Procedures for preparing BHV-1 genomic DNA have been described previously
(18, 30–32). 9.1.3 cells were cotransfected with the gCblue viral DNA and one of
the plasmids encoding bICP0, C/EBP-␣, C/EBP-␣⌬DB, or empty expression
vector (pcDNA3.1⫺) using Lipofectamine 2000 (Invitrogen). ␤-Galactosidasepositive (␤-Gal⫹) cells were counted at 24 h after transfection as described
previously (18, 30–32). The number of ␤-Gal⫹ cells in cultures transfected with
pcDNA3.1⫺ and gCblue genomic DNA was set at a value of 1 for each experiment. All other transfections were examined for ␤-Gal⫹ cells and are expressed
as induction (n-fold) relative to the control. This representation of the data
minimizes differences in cell density, variation in Lipofectamine 2000 lots, and
transfection efficiency.

RESULTS
Identification of cellular proteins that interact with the LR
fusion protein. The bacterial two-hybrid system was used to
identify cellular proteins that bind to the LR fusion protein. A
fragment containing the 7d cDNA (11) (Fig. 1) was cloned into
the pBT vector such that the major ORF was in frame with cI
coding sequences (pBT7day). Since BHV-1 can replicate in
cottontail rats (48), a commercially available rat brain cDNA
library was used as target sequences. Cotransformation of E.
coli with the pBT7day and pTRG plasmids resulted in several
positive colonies. Rat cDNA inserts were sequenced, and
BLAST analysis was performed to identify cellular proteins
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TABLE 1. Rat proteins that interact with the LR fusion protein
encoded by 7d cDNAa
Description of protein

GenBank
accession no.

Apoptosis regulator
BH3 domain from Bid.........................................................BC023963
Cdc42 (GTPase) ...................................................................NM009861
BCR-related gene.................................................................BC043673
NADH dehydrogenase 4, mitochondrial...........................BC020382
Transcription factor
CCAAT enhancer binding protein ....................................BC011319
High mobility group nuclear protein 2 (Hmgn2) ............NM016957
Topoisomerase 1 binding protein (Btbd2)........................XM354550

(approximately 27 kDa) (Fig. 2A) was smaller than the human
homolog (approximately 33 kDa) (Fig. 2B).
To test whether the LR fusion protein interacted with mammalian C/EBP-␣, the recombinant LR fusion protein was
bound to the Ni⫹ column under denaturing conditions. Wholecell extract prepared from SK-N-SH cells was subsequently
incubated with the LR fusion protein that was immobilized on
the Ni⫹ column. Under denaturing conditions, the insect
C/EBP-␣ protein was not retained in the Ni⫹ column (Fig. 2B,
lane 2). When SK-N-SH cell extract was incubated with the
column containing the LR fusion protein, a band of the expected size of human C/EBP-␣ (approximately 33 kDa) was

Other
Elongation factor 1-alpha 1 homologue............................AK088041
Ribosomal phosphoprotein P0 ...........................................BC003833
Ubiquitin C ...........................................................................NM019639
B-cell and monocyte-activating chemokine precursor.....AF144754
RIKEN cDNA 2610510H01 gene ......................................BC005803
RIKEN cDNA D130012J15 gene ......................................NM172271
a
Procedures for performing the BacterioMatch II two-hybrid screening are
described in Materials and Methods.

that interacted with the LR fusion protein (Table 1). As expected, we did not obtain positive colonies when bacteria were
transformed with pTRG or pBT7day alone.
Two cellular genes that encode proapoptotic proteins (the
BH3 domain of Bid and Cdc42) and two other genes that
encode proteins with potential roles in apoptosis (NADH dehydrogenase 4 and a BCR-related gene) were identified in the
two-hybrid screening (Table 1). The Bcr protein is a GTPaseactivating protein (14), suggesting that it activates the GTPase
activity of Cdc42. Since the LR gene can inhibit apoptosis in
cultured cells (10, 25) and TG of infected calves (43), we
expected that LR proteins would interact with proapoptotic
proteins. Determining the significance of the other binding
proteins will require additional studies. We began by examining the significance of the LR fusion protein interacting with
C/EBP-␣.
The LR fusion protein interacts with human and insect
C/EBP-␣. The interaction between C/EBP-␣ and the BHV-1
LR fusion protein (Table 1) was of particular interest because
Epstein-Barr virus (EBV), human herpesvirus 8 (HHV-8), and
herpesvirus saimiri (HVS) productive infections are stimulated
by C/EBP-␣ (28, 60, 62, 67). To confirm the interaction between the LR fusion protein and C/EBP-␣, a recombinant
baculovirus that expresses the LR fusion protein as a histidinetagged protein (recombinant baculovirus His66) (33) was used.
Because mammalian C/EBP-␣ shares significant homology
with the Drosophila melanogaster homolog (64), we tested
whether the insect C/EBP-␣ homolog was bound to the Histagged LR fusion protein. SF9 insect cells were infected with
the recombinant baculovirus His66, and infected cells were
lysed and then loaded onto a Ni⫹ affinity column using native
conditions to preserve protein-protein interactions. A Western
blot analysis of proteins bound to the column demonstrated
that insect C/EBP-␣ was retained in the Ni⫹ column only when
SF9 cells were infected with the recombinant baculovirus
His66 (Fig. 2A, lane 4). We also noted that the insect C/EBP-␣

FIG. 2. The LR fusion protein binds to the C/EBP-␣ protein expressed in SF9 cells and human neuroblastoma cells (SK-N-SH).
(A) Eleven milligrams of cell lysate prepared from uninfected SF9 cells
(SF9) or SF9 cells infected with the His66 baculovirus (SF9-His66)
were bound to the Ni⫹ column using native conditions. After the
column was washed, the column beads were boiled in SDS reducing
buffer and the bound proteins electrophoresed by 12% SDS-PAGE.
Lanes 1 and 3 contain 250 g of the indicated whole-cell lysate.
Proteins were transferred to a PVDF membrane and probed with
anti-C/EBP-␣ antibody that was diluted 1:500. The arrow denotes the
position of the insect C/EBP-␣ homolog (approximately 27 kDa).
Lanes 2 and 4 contain proteins bound to the Ni⫹ column. (B) Eleven
milligrams of uninfected (SF9) or infected (SF9-His66) insect cell
lysate was prepared using denaturing conditions (see Materials and
Methods), and the protein was then applied to a Ni⫹ column. Unbound proteins were removed by washing the column. Three milligrams of cell lysate prepared from SK-N-SH cells was then incubated
for 1 h with the Ni⫹ column. Unbound protein was removed by extensive washing as described in Materials and Methods. Column beads
were boiled in SDS reducing buffer, and proteins were electrophoresed
by 12% SDS-PAGE, transferred to a PVDF membrane, and then
probed with the anti-C/EBP-␣ antibody diluted 1:500. The closed circle denotes the ⬃33-kDa C/EBP-␣ detected with SK-N-SH cells, and
the arrow denotes the position of the insect C/EBP-␣ homolog. Lanes
1 and 3 contain 250 g of the indicated cell lysate. Lanes 2, 4, 5, and
6 contain proteins that were bound to the Ni⫹ column. Molecular
weight markers are in kilodaltons.
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FIG. 3. Expression of C/EBP-␣ during productive infection.
MDBK cells were infected with wt BHV-1 (V) using a multiplicity of
infection of 5, and whole-cell lysate was collected at 6, 14, 24, or 30 h
after infection. M, mock-infected cells. Cells were lysed with NP-40
lysis buffer, and 250 g of protein was electrophoresed by 12% SDSPAGE. Proteins in the gel were transferred onto a PVDF membrane
and probed with anti-C/EBP-␣ that was diluted 1:500. The arrow
denotes the 42-kDa isoform of C/EBP-␣, and the closed circle denotes
a 35-kDa band that was recognized by the antibody. Molecular weight
markers are in kilodaltons.

retained in the Ni⫹ column and was recognized by the
C/EBP-␣ antibody (Fig. 2B, lane 5). In contrast, when only SF9
cell extract was incubated with the column, human C/EBP-␣
was not bound to the column (Fig. 2B, lane 6). As expected,
the human C/EBP-␣ protein was not retained on the Ni⫹
column lacking the LR fusion protein (Fig. 2B, lane 4). In
summary, these results demonstrated that the LR fusion protein interacted with human or insect C/EBP-␣ protein.
Analysis of C/EBP-␣ protein expression following infection
of bovine cells. Since the LR fusion protein interacted with the
C/EBP-␣ protein, we tested whether C/EBP-␣ protein levels
were altered during viral infection. During the course of productive infection, a prominent 41-kDa protein in infected cells
was induced; it was recognized by the C/EBP-␣ antibody (Fig.
3, lanes V). This 41-kDa protein is the approximate size of the
long translational form of C/EBP-␣ (41, 47). The levels of a
33-kDa band recognized by the C/EBP-␣ antibody increased in
mock-infected MDBK cells as a function of time after plating
(Fig. 3, lanes M). Induction of the 41-kDa protein recognized
by the C/EBP-␣ antibody was detected at 24 h after infection
when cells were infected at a high (5) or low (0.01) multiplicity
of infection (Fig. 3 and data not shown). In summary, these
studies suggested that BHV-1 infection of cultured cells led to
induction of the long form of C/EBP-␣.
Analysis of C/EBP-␣ expression in TG of infected calves. To
examine C/EBP-␣ protein expression in TG of infected calves,
immunohistochemistry was performed using the C/EBP-␣ specific antibody. C/EBP-␣ protein expression was readily detected in TG neurons of calves that were infected for 4 or 7
days (Fig. 4). At 4 days after infection, C/EBP-␣ protein expression was primarily localized to the perinuclear region,
whereas at 7 days after infection, C/EBP-␣ was detected in the
nucleus of certain neurons. In contrast, C/EBP-␣ protein expression was not detected in TG neurons of an uninfected calf
(Fig. 4). However, a few nonneuronal cells in all calves, including mock-infected calves, expressed C/EBP-␣. At 14 days after
infection, there appeared to be slight neuronal staining (Fig.
4), which was not observed in mock-infected calves or at 60
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days after infection (latency) (data not shown). Calves latently
infected with BHV-1 undergo reactivation from latency following administration of DEX, a synthetic corticosteroid (54). At
24 (Fig. 4) or 48 (data not shown) h after a single dose of DEX,
C/EBP-␣ protein expression was readily detected in a subset of
TG neurons. In contrast, when a mock-infected calf was administered the same dose of DEX for 24 h, C/EBP-␣ protein
expression was not detected in TG neurons (Fig. 4).
RT-PCR was performed on TG samples of calves infected
with wt BHV-1 or left uninfected. C/EBP-␣, but not GH, RNA
levels were higher at 6 days after infection than at 10 or 14 days
after infection (Fig. 5). Although C/EBP-␣ RNA was detected
in mock-infected calves (Fig. 5), we assume expression occurred in nonneuronal cells or C/EBP-␣ was unstable in neurons, because it was not detected in TG neurons prepared from
mock-infected calves (Fig. 4). In summary, these studies indicated that C/EBP-␣ protein expression was detected in TG
neurons of acutely infected calves or following DEX-induced
reactivation from latency.
wt C/EBP-␣, but not a DNA binding mutant, increases
plaque formation. Since C/EBP-␣ stimulates HHV-8, HVS, or
EBV gene expression and productive infection (28, 60, 62, 67),
we hypothesized that C/EBP-␣ may enhance BHV-1 productive infection. To test whether the overexpression of C/EBP-␣
enhanced plaque formation, bovine cells were cotransfected
with gCblue genomic DNA and increasing concentrations of wt
pC/EBP-␣ or a DNA binding mutant (pC/EBP-␣⌬DB) (Fig.
6). Transfection of 9.1.3 cells with BHV-1 genomic DNA yields
low levels of infectious virus. Cotransfection of BHV-1 DNA
with a plasmid expressing bICP0 enhances productive infection
and virus yield (Fig. 6) (32). At 24 h after transfection, cells
were fixed and ␤-Gal⫹ cells identified. This time point was
used as the time to count ␤-Gal⫹ cells to minimize the number
of virus-positive cells that result from virus spread. Furthermore, at later times, many of the ␤-Gal⫹ cells lift off the dish,
making it difficult to count virus-positive cells (18, 32). The
number of ␤-Gal⫹ cells directly correlates with the number of
plaques produced following transfection with the BHV-1 blue
virus (17, 18, 32). When a 16:1 molar ratio of pC/EBP-␣ to
genomic gCblue viral DNA was cotransfected into 9.1.3 cells, a
threefold increase in plaques was observed relative to pC/EBP␣⌬DB or the blank expression vector (Fig. 6). At high concentrations of pC/EBP-␣, the number of plaques was slightly lower
than the numbers obtained with the empty expression vector or
with equivalent amounts of pC/EBP-␣⌬DB. pC/EBP-␣ was
less efficient than bICP0 at activating productive infection,
even when transfected at four times the level of bICP0.
DISCUSSION
In this study, we identified cellular proteins that interact with
the major ORF encoded by an alternatively spliced polyadenylated LR transcript that is abundantly expressed in TG of
calves at 7 days after infection (11, 12). Seven days after infection is important with respect to establishing latency in calves,
because after this time most viral gene expression is extinguished in TG (57). Only the LR gene (40) and ORF-E (29)
are abundantly expressed after 7 days postinfection. Therefore,
we predicted that LR proteins, in part, regulate the transition
between productive infection and establishment of latency.
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FIG. 4. Analysis of C/EBP-␣ protein expression in TG of BHV-1-infected calves. At the indicated times after infection, thin sections of TG were
prepared and stained with the anti-C/EBP-␣ antibody as described in Materials and Methods. Arrows denote C/EBP-␣ positive neurons.
Magnification, ⫻400. dpi, days postinfection; 24 DEX, 24 h after DEX treatment.

The ability of the LR gene (10, 25) and products encoded by
the 7d cDNA (data not shown) to inhibit apoptosis correlates
with the LR gene being necessary for reactivation from latency
after DEX treatment (31). During the transition from acute
infection to establishment of latency, an LR mutant virus induces higher levels of apoptosis in TG of infected calves, which
reduces establishment from latency (43). Furthermore, insertion of the wt LR gene (52), but not the LR gene containing
stop codons at the 5⬘ terminus of ORF-2 (45), into a herpes
simplex virus type 1 latency-associated transcript minus mutant
virus restores high levels of spontaneous reactivation in the
rabbit eye model and explant-induced reactivation. Finally, the
ability of herpes simplex virus type 1 latency-associated transcript to inhibit apoptosis is crucial for wt levels of reactivation

from latency (34). Taken together, these observations suggest
that the ability of the LR gene to inhibit apoptosis is one
function that promotes the establishment of latency in a pool
of neurons that can subsequently reactivate from latency.
The results from this study suggested that the antiapoptotic
functions of the LR gene rely on the ability of LR proteins
to interact with Bid or Cdc42. Bid links the extrinsic pathway
of apoptosis to the intrinsic pathway; following cleavage by
caspase 8, Bid interacts with mitochondria (42), inducing cytochrome C and Smac/Diablo release (63). Bid is also specifically cleaved by granzyme B (3, 4, 53), suggesting that the
ability of LR proteins to interact with Bid impairs cytotoxic
T-lymphocyte-induced death of infected neurons. Neuronal
stress, including removal of nerve growth factor from neuronal
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FIG. 5. Detection of C/EBP-␣ RNA in TG of BHV-1-infected cattle. RT-PCR for C/EBP-␣ was performed using RNA prepared from TG on
the indicated days after infection or from a mock-infected calf (Mock). RNA extraction, RT-PCR, and PCR were performed as described in
Materials and Methods. The cDNA for the respective samples was generated with random primers. Bovine GH was used as an internal control
for cDNA amplification and DNA contamination. Positive (GH⫹) and negative (GH⫺) RT-PCRs (without reverse transcriptase) are shown. The
first lane contains a 100-bp DNA ladder (New England BioLabs).

cultures (39, 68), induces activity of Cdc42, a Rho GTPase
family member (24). When PC12 cells (rat neuron-like cell
line) are treated with nerve growth factor, they differentiate
and behave like mature sympathetic neurons (19, 20). If PC12
cells or primary sympathetic neurons are deprived of nerve
growth factor, Cdc42 is activated, resulting in apoptosis (39,
68). Since DEX reproducibly induces BHV-1 reactivation from
latency (1, 2, 7, 26, 37, 54, 58, 66) and DEX is a potent stressor,
Cdc42 may be activated in TG.
C/EBPs belong to the bZIP (basic and leucine zipper domain) family of transcription factors (64). The D. melanogaster
genome contains 27 bZIP genes, of which 21 have a mammalian counterpart (15). Two of these bZIP proteins have homology with human C/EBP-␣ outside the bZIP region, showing
76% and 36% identity in the basic region and 23% and 28%
identity in the leucine zipper (15). The C/EBP-␣ mRNA is
translated into a 30- or 42-kDa protein, because there is an
in-frame ATG codon downstream of the first ATG and both
ATGs can be used as start codons. The shorter form of

C/EBP-␣ retains dimerization and DNA binding domains but
possesses altered trans-activation potential (41), because the
N-terminal domain contains trans-activating domains (41, 47).
C/EBP-␣ regulates cell cycle regulation and differentiation
(41), suggesting that interactions with the LR fusion protein
helps neurons recover from infection.
The interaction between the LR fusion protein and
C/EBP-␣ may also influence viral gene expression, because
C/EBP-␣ stimulates lytic gene transcription of EBV, HHV-8,
and HVS (28, 60, 62, 67). C/EBP-␣ binds to the major lytic
viral transactivators of EBV and HHV-8, Zta and Rta proteins,
respectively. Binding of viral activators stabilizes C/EBP-␣, and
the protein complex directly binds to viral IE promoters to
activate viral transcription (28, 62, 67). Several lines of evidence suggested that C/EBP-␣ enhanced BHV-1 productive
infection. First, a BHV-1-encoded or -induced product led to
the induction of the full-length C/EBP-␣ isoform, or C/EBP-␣
was posttranslationally modified (Fig. 3). Secondly, there was a
positive correlation between viral gene expression in TG and

FIG. 6. The DNA binding domain of C/EBP-␣ is necessary to enhance productive infection. Bovine cells (9.1.3) were cotransfected with
increasing amounts of pC/EBP-␣ or pC/EBP-␣⌬DB (13 ng, 52 ng, 0.21 g, 0.83 g, or 3.32 g) or bICP0 (52 ng), and the gCblue virus genome
(0.83 g DNA). Ratios of pC/EBP-␣ or pC/EBP-␣⌬DB DNA molecules to viral genomic DNA molecules are 1:1, 4:1, 16:1, 64:1, or 256:1,
respectively. The ratio between bICP0 molecules and viral DNA molecules is 4:1. An empty expression vector (pcDNA3.1⫺) was used to maintain
equivalent amounts of DNA. At 24 h after transfection, cells were fixed and stained, and the number of ␤-Gal⫹ cells was counted. The number
of ␤-Gal⫹ cells in the vector control (pcDNA3.1⫺) was set at onefold. The number of ␤-Gal⫹ cells in each well was calculated as the change
(n-fold) compared to the vector control. The results are the averages from three independent experiments.
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C/EBP-␣ protein expression (Fig. 4) because C/EBP-␣ was
detected in TG neurons at times (4 and 7 days after infection)
when viral gene expression (57) and infectious virus (31) are
detected. Finally, wt C/EBP-␣, but not a DNA binding mutant,
enhanced BHV-1 plaque formation (Fig. 6). These studies
suggested that C/EBP-␣ activates certain key BHV-1 promoters, directly or indirectly, which is consistent with the role that
C/EBP-␣ plays in EBV, HHV8, or HVS productive infection.
We hypothesize that, in addition to inhibiting apoptosis, interactions between the LR fusion protein and C/EBP-␣ repress
productive infection, thus promoting the establishment of latency in neurons that can support reactivation from latency.
Studies designed to test these predictions are in progress.
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